The U.S. healthcare delivery model is undergoing dramatic changes, with the PBM “Big 3” all announcing mergers in recent months, and Amazon and other entities looking at ways to disrupt the traditional healthcare value chain.

What opportunities and threats should pharma strategists keep an eye on as they navigate the changes ahead?

 

Download the full report to learn more about how each of the above opportunities and threats may change the game for pharma companies:

 

Massachusetts Enhances Ability to Negotiate Medicaid Drug Rebates

View Now